Summary
Overview
Work History
Education
Skills
Accomplishments
Timeline
Generic

Erica Tien

WORCESTER

Summary

  • Experienced Sr. Scientist II with a robust background in target discovery platforms, encompassing small molecules, next-generation antibody platform development, CRISPR screening and shRNA/RNAi profiling.
  • Recognized project manager and leader in diverse internal and external projects, specializing in autoimmune disease areas such as Hidradenitis Suppurativa, Rheumatoid arthritis, SLE, and Atopic Dermatitis.
  • Proficient in executing next-generation sequencing methods including Bulk RNA-Seq, scRNA-Seq, Oink, TCR BCR Sequencing and Spatial Transcriptomics for advanced immunology discovery programs.
  • Adept collaborator and communicator, fostering effective teamwork both internally and externally.

Overview

14
14
years of professional experience

Work History

Sr. Scientist II Transformational & Translational

AbbVie
08.2021 - Current
  • Lead and executing Bulk RNA-Seq, scRNA-Seq and Spatial workflows, managing tasks from tissue storage and sample preparation to data generation specializing in autoimmune disease area.
  • Support the pathology group in advancing the growth of single-cell spatial multiomic technology in drug development by participating in the development, execution, validation, and troubleshooting of single-cell and spatial multiomic assays for autoimmune diseases.
  • Collaborating in automated workflow design and execute experimentation for instrument selection or refinement/improvement of sample processes.
  • Managing portfolio disease projects focusing on disease area Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) ensure each project aligns with overarching goals and objectives.
  • Support the design and execution of proof-of-concept experiments to initiate portfolio entry for new therapy programs.
  • Work with clinical team to design sample collection kits, laboratory manual, and specimen logistics for shipments to third party vendors.
  • Coordinated with multiple teams and managed CROs in a highly matrixed environment.
  • Mentor and coach team members to help achieve the project goals.

Scientist Project Lead

Skyhawk Therapeutics
05.2019 - 08.2020
  • Development and of current and new protocols on a variety of sample types such as whole blood, FFPE tissue samples and plasma. (bulk RNA-Seq, Drug-Seq, scRNA-Seq, Smart-Seq, Drug-Seq, CITE-Seq, and long-read sequencing Nanopore sequencing platform).
  • Tested and validated a low-cost and HTS NGS based (3’UPX kit) to proof-of-concept screening for novel compound mechanistic studies and compound repurposing efforts.
  • Designed and Developed PCR-based assays for quantifying gene expression.
  • Serve as a knowledgeable resource for variety single-cell technology, provide guidance on experimental design, method or platform selection.
  • Utilize available resources to achieve timely execution of projects and collaborate with cross-functional teams (internal and external) to execute plans and deliverables.
  • Provided scientific and operational oversight of CROs and other ancillary vendors.
  • Educate other associate scientists, provide hands-on training, and give internal and external presentations.

Research Scientist Sequencing Core

Boston University
12.2017 - 05.2019
  • Developed, validated and troubleshooted on bulk RNA-Seq, scRNA-Seq (such as Smart-Seq, Cel-Seq,10X Genomic) on difficult clinical specimen.
  • Developed and optimized new tissue dissociation, immune cell purification and PBMC isolation protocols to expanded services by the scRNA-Seq core.
  • Coordinated and led research projects for clinical samples screen, Illumina platform, and scRNA-Seq for therapeutic discovery.
  • Successfully completed over 50 academic and industrial client’s projects for over 1000 samples from BUMC, BU and pharmaceutical companies.


Research Scientist

Pfizer
07.2016 - 05.2017
  • Developed and improved protocols for human iPSC/ESC to cardiomyocyte, hepatocytes and neuron cells.
  • Reprogrammed human skin fibroblasts and hematopoietic stem cells by retroviral methods into iPSC stem cells.
  • Gene expression profiling experimental design, RNA isolation and QC, differential gene expression analysis follow up validation with qPCR and providing biomarkers and MOA based on expression and pathway analysis.
  • Optimized transfection conditions for genome-editing tools such as CRISPR and siRNA overexpression construct delivery.
  • Developed multiplexed phenotypic assays for cellular and drug target biology utilizing chemical genomics, RNAi, lentivirus, CRISPR, and overexpression platforms.

Postdoctoral Fellow

University of Connecticut
05.2013 - 03.2016
  • Developed animal models to predict variation of drugs response and Drug-Drug interaction.
  • Differentiation of human Cardiac iPSCs for Drug Screening & Discovery.
  • Next generation RNA sequencing samples QC, library preparation, data analysis.
  • Phenotypic Screens in 96-well format to identify and validate targets for CVD using physiologically relevant cell models (differentiated cell lines, stem cells, primary cells).
  • Collaborated with PI and colleague to conceptualize, edit, and contribute data to an NIH R01 grant.

Postdoctoral Research Fellow

Yale University Department of Pharmacology
07.2011 - 08.2012
  • Dose- response expression profiling for MOA study of compound efficacy, toxicity, and off-target activity in tissue culture.
  • Compound profiling and mechanism of actions studies for therapeutic molecules against a broad range of molecular targets, including enzymes kinetics and GPCRs.
  • Established international collaboration with leading labs to test "actives" from a screen of 10K compounds and identified compounds for further testing in preclinical trials
  • Phase II study of PHY906 combining CPT-11 in advanced hepatocellular carcinoma.

Education

Ph.D. - Pharmacology

China Medical University
Taiwan
07-2012

Skills

  • Single-Cell and RNA Sequencing
  • Proficient in single-cell and single-nucleus isolation from tissue and blood from clinical trial
  • Skilled in different library preparation using 10x Genomics Chromium and other single-cell platforms
  • Project Management

Accomplishments

  • AbbVie VP Award 2022
  • James R. Gillette Best Paper Award. The 1st place award for Postdoctoral Fellow
  • Travel award for The American for Pharmacology and Experimental Therapeutics
  • First Place award from The American association for Pharmacology
  • Graduate Study Abroad Program provided by the National Science Council.
  • Departmental Honors for Senior Thesis provided by the College of Pharmacy, Taiwan.
  • First Place award for Pharmacology PhD students, Taiwan

Timeline

Sr. Scientist II Transformational & Translational

AbbVie
08.2021 - Current

Scientist Project Lead

Skyhawk Therapeutics
05.2019 - 08.2020

Research Scientist Sequencing Core

Boston University
12.2017 - 05.2019

Research Scientist

Pfizer
07.2016 - 05.2017

Postdoctoral Fellow

University of Connecticut
05.2013 - 03.2016

Postdoctoral Research Fellow

Yale University Department of Pharmacology
07.2011 - 08.2012

Ph.D. - Pharmacology

China Medical University
Erica Tien